{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 249,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import codecs\n",
    "from matplotlib import pyplot as plt\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 240,
   "metadata": {},
   "outputs": [],
   "source": [
    "product = pd.read_csv('product.csv', encoding = \"ISO-8859-1\")\n",
    "#package = pd.read_csv('package.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 241,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PRODUCTID</th>\n",
       "      <th>PRODUCTNDC</th>\n",
       "      <th>PRODUCTTYPENAME</th>\n",
       "      <th>PROPRIETARYNAME</th>\n",
       "      <th>PROPRIETARYNAMESUFFIX</th>\n",
       "      <th>NONPROPRIETARYNAME</th>\n",
       "      <th>DOSAGEFORMNAME</th>\n",
       "      <th>ROUTENAME</th>\n",
       "      <th>STARTMARKETINGDATE</th>\n",
       "      <th>ENDMARKETINGDATE</th>\n",
       "      <th>MARKETINGCATEGORYNAME</th>\n",
       "      <th>APPLICATIONNUMBER</th>\n",
       "      <th>LABELERNAME</th>\n",
       "      <th>SUBSTANCENAME</th>\n",
       "      <th>ACTIVE_NUMERATOR_STRENGTH</th>\n",
       "      <th>ACTIVE_INGRED_UNIT</th>\n",
       "      <th>PHARM_CLASSES</th>\n",
       "      <th>DEASCHEDULE</th>\n",
       "      <th>NDC_EXCLUDE_FLAG</th>\n",
       "      <th>LISTING_RECORD_CERTIFIED_THROUGH</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0002-0800_4bb5d1cb-0fa7-48c7-9f6d-8d45f9b91649</td>\n",
       "      <td>0002-0800</td>\n",
       "      <td>HUMAN OTC DRUG</td>\n",
       "      <td>Sterile Diluent</td>\n",
       "      <td>NaN</td>\n",
       "      <td>diluent</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>1987-07-10</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA018781</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>WATER</td>\n",
       "      <td>1</td>\n",
       "      <td>mL/mL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>N</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0002-1200_957ee1b5-dfa7-4e3f-96e1-6bed1ffc0abe</td>\n",
       "      <td>0002-1200</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Amyvid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Florbetapir F 18</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>INTRAVENOUS</td>\n",
       "      <td>2012-06-01</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA202008</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>FLORBETAPIR F-18</td>\n",
       "      <td>51</td>\n",
       "      <td>mCi/mL</td>\n",
       "      <td>Radioactive Diagnostic Agent [EPC],Positron Em...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>N</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0002-1407_14757f9d-f641-4836-acf3-229265588d1d</td>\n",
       "      <td>0002-1407</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Quinidine Gluconate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Quinidine Gluconate</td>\n",
       "      <td>SOLUTION</td>\n",
       "      <td>INTRAVENOUS</td>\n",
       "      <td>1950-07-12</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA007529</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>QUINIDINE GLUCONATE</td>\n",
       "      <td>80</td>\n",
       "      <td>mg/mL</td>\n",
       "      <td>Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhib...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>N</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0002-1433_7b0ec07f-bffa-467f-978a-45b1315107e5</td>\n",
       "      <td>0002-1433</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Trulicity</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Dulaglutide</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>2014-09-18</td>\n",
       "      <td>NaT</td>\n",
       "      <td>BLA</td>\n",
       "      <td>BLA125469</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>DULAGLUTIDE</td>\n",
       "      <td>0.75</td>\n",
       "      <td>mg/.5mL</td>\n",
       "      <td>GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>N</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0002-1434_7b0ec07f-bffa-467f-978a-45b1315107e5</td>\n",
       "      <td>0002-1434</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Trulicity</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Dulaglutide</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>2014-09-18</td>\n",
       "      <td>NaT</td>\n",
       "      <td>BLA</td>\n",
       "      <td>BLA125469</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>DULAGLUTIDE</td>\n",
       "      <td>1.5</td>\n",
       "      <td>mg/.5mL</td>\n",
       "      <td>GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>N</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        PRODUCTID PRODUCTNDC  \\\n",
       "0  0002-0800_4bb5d1cb-0fa7-48c7-9f6d-8d45f9b91649  0002-0800   \n",
       "1  0002-1200_957ee1b5-dfa7-4e3f-96e1-6bed1ffc0abe  0002-1200   \n",
       "2  0002-1407_14757f9d-f641-4836-acf3-229265588d1d  0002-1407   \n",
       "3  0002-1433_7b0ec07f-bffa-467f-978a-45b1315107e5  0002-1433   \n",
       "4  0002-1434_7b0ec07f-bffa-467f-978a-45b1315107e5  0002-1434   \n",
       "\n",
       "           PRODUCTTYPENAME      PROPRIETARYNAME PROPRIETARYNAMESUFFIX  \\\n",
       "0           HUMAN OTC DRUG      Sterile Diluent                   NaN   \n",
       "1  HUMAN PRESCRIPTION DRUG               Amyvid                   NaN   \n",
       "2  HUMAN PRESCRIPTION DRUG  Quinidine Gluconate                   NaN   \n",
       "3  HUMAN PRESCRIPTION DRUG            Trulicity                   NaN   \n",
       "4  HUMAN PRESCRIPTION DRUG            Trulicity                   NaN   \n",
       "\n",
       "    NONPROPRIETARYNAME       DOSAGEFORMNAME     ROUTENAME STARTMARKETINGDATE  \\\n",
       "0              diluent  INJECTION, SOLUTION  SUBCUTANEOUS         1987-07-10   \n",
       "1     Florbetapir F 18  INJECTION, SOLUTION   INTRAVENOUS         2012-06-01   \n",
       "2  Quinidine Gluconate             SOLUTION   INTRAVENOUS         1950-07-12   \n",
       "3          Dulaglutide  INJECTION, SOLUTION  SUBCUTANEOUS         2014-09-18   \n",
       "4          Dulaglutide  INJECTION, SOLUTION  SUBCUTANEOUS         2014-09-18   \n",
       "\n",
       "  ENDMARKETINGDATE MARKETINGCATEGORYNAME APPLICATIONNUMBER  \\\n",
       "0              NaT                   NDA         NDA018781   \n",
       "1              NaT                   NDA         NDA202008   \n",
       "2              NaT                   NDA         NDA007529   \n",
       "3              NaT                   BLA         BLA125469   \n",
       "4              NaT                   BLA         BLA125469   \n",
       "\n",
       "             LABELERNAME        SUBSTANCENAME ACTIVE_NUMERATOR_STRENGTH  \\\n",
       "0  Eli Lilly and Company                WATER                         1   \n",
       "1  Eli Lilly and Company     FLORBETAPIR F-18                        51   \n",
       "2  Eli Lilly and Company  QUINIDINE GLUCONATE                        80   \n",
       "3  Eli Lilly and Company          DULAGLUTIDE                      0.75   \n",
       "4  Eli Lilly and Company          DULAGLUTIDE                       1.5   \n",
       "\n",
       "  ACTIVE_INGRED_UNIT                                      PHARM_CLASSES  \\\n",
       "0              mL/mL                                                NaN   \n",
       "1             mCi/mL  Radioactive Diagnostic Agent [EPC],Positron Em...   \n",
       "2              mg/mL  Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhib...   \n",
       "3            mg/.5mL  GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...   \n",
       "4            mg/.5mL  GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...   \n",
       "\n",
       "  DEASCHEDULE NDC_EXCLUDE_FLAG LISTING_RECORD_CERTIFIED_THROUGH  \n",
       "0         NaN                N                       2019-12-31  \n",
       "1         NaN                N                       2019-12-31  \n",
       "2         NaN                N                       2019-12-31  \n",
       "3         NaN                N                       2019-12-31  \n",
       "4         NaN                N                       2019-12-31  "
      ]
     },
     "execution_count": 241,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# convert time into time format\n",
    "product['ENDMARKETINGDATE'] = pd.to_datetime(product['ENDMARKETINGDATE'], format='%Y%m%d', errors='ignore')\n",
    "product['STARTMARKETINGDATE'] = pd.to_datetime(product['STARTMARKETINGDATE'], format='%Y%m%d', errors='ignore')\n",
    "product['LISTING_RECORD_CERTIFIED_THROUGH'] = pd.to_datetime(product['LISTING_RECORD_CERTIFIED_THROUGH'], format='%Y%m%d', errors='ignore')\n",
    "# remove all the products which are out of date\n",
    "product = product[(product['ENDMARKETINGDATE']>'2019-03-16') | (product['ENDMARKETINGDATE'].isnull())]\n",
    "product = product[product['LISTING_RECORD_CERTIFIED_THROUGH']>'2019-03-16']\n",
    "product.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 242,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PRODUCTID</th>\n",
       "      <th>PRODUCTNDC</th>\n",
       "      <th>PRODUCTTYPENAME</th>\n",
       "      <th>PROPRIETARYNAME</th>\n",
       "      <th>NONPROPRIETARYNAME</th>\n",
       "      <th>DOSAGEFORMNAME</th>\n",
       "      <th>ROUTENAME</th>\n",
       "      <th>STARTMARKETINGDATE</th>\n",
       "      <th>ENDMARKETINGDATE</th>\n",
       "      <th>MARKETINGCATEGORYNAME</th>\n",
       "      <th>APPLICATIONNUMBER</th>\n",
       "      <th>LABELERNAME</th>\n",
       "      <th>SUBSTANCENAME</th>\n",
       "      <th>ACTIVE_NUMERATOR_STRENGTH</th>\n",
       "      <th>ACTIVE_INGRED_UNIT</th>\n",
       "      <th>PHARM_CLASSES</th>\n",
       "      <th>LISTING_RECORD_CERTIFIED_THROUGH</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0002-0800_4bb5d1cb-0fa7-48c7-9f6d-8d45f9b91649</td>\n",
       "      <td>0002-0800</td>\n",
       "      <td>HUMAN OTC DRUG</td>\n",
       "      <td>Sterile Diluent</td>\n",
       "      <td>diluent</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>1987-07-10</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA018781</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>WATER</td>\n",
       "      <td>1</td>\n",
       "      <td>mL/mL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0002-1200_957ee1b5-dfa7-4e3f-96e1-6bed1ffc0abe</td>\n",
       "      <td>0002-1200</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Amyvid</td>\n",
       "      <td>Florbetapir F 18</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>INTRAVENOUS</td>\n",
       "      <td>2012-06-01</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA202008</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>FLORBETAPIR F-18</td>\n",
       "      <td>51</td>\n",
       "      <td>mCi/mL</td>\n",
       "      <td>Radioactive Diagnostic Agent [EPC],Positron Em...</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0002-1407_14757f9d-f641-4836-acf3-229265588d1d</td>\n",
       "      <td>0002-1407</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Quinidine Gluconate</td>\n",
       "      <td>Quinidine Gluconate</td>\n",
       "      <td>SOLUTION</td>\n",
       "      <td>INTRAVENOUS</td>\n",
       "      <td>1950-07-12</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA007529</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>QUINIDINE GLUCONATE</td>\n",
       "      <td>80</td>\n",
       "      <td>mg/mL</td>\n",
       "      <td>Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhib...</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0002-1433_7b0ec07f-bffa-467f-978a-45b1315107e5</td>\n",
       "      <td>0002-1433</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Trulicity</td>\n",
       "      <td>Dulaglutide</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>2014-09-18</td>\n",
       "      <td>NaT</td>\n",
       "      <td>BLA</td>\n",
       "      <td>BLA125469</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>DULAGLUTIDE</td>\n",
       "      <td>0.75</td>\n",
       "      <td>mg/.5mL</td>\n",
       "      <td>GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0002-1434_7b0ec07f-bffa-467f-978a-45b1315107e5</td>\n",
       "      <td>0002-1434</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Trulicity</td>\n",
       "      <td>Dulaglutide</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>2014-09-18</td>\n",
       "      <td>NaT</td>\n",
       "      <td>BLA</td>\n",
       "      <td>BLA125469</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>DULAGLUTIDE</td>\n",
       "      <td>1.5</td>\n",
       "      <td>mg/.5mL</td>\n",
       "      <td>GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        PRODUCTID PRODUCTNDC  \\\n",
       "0  0002-0800_4bb5d1cb-0fa7-48c7-9f6d-8d45f9b91649  0002-0800   \n",
       "1  0002-1200_957ee1b5-dfa7-4e3f-96e1-6bed1ffc0abe  0002-1200   \n",
       "2  0002-1407_14757f9d-f641-4836-acf3-229265588d1d  0002-1407   \n",
       "3  0002-1433_7b0ec07f-bffa-467f-978a-45b1315107e5  0002-1433   \n",
       "4  0002-1434_7b0ec07f-bffa-467f-978a-45b1315107e5  0002-1434   \n",
       "\n",
       "           PRODUCTTYPENAME      PROPRIETARYNAME   NONPROPRIETARYNAME  \\\n",
       "0           HUMAN OTC DRUG      Sterile Diluent              diluent   \n",
       "1  HUMAN PRESCRIPTION DRUG               Amyvid     Florbetapir F 18   \n",
       "2  HUMAN PRESCRIPTION DRUG  Quinidine Gluconate  Quinidine Gluconate   \n",
       "3  HUMAN PRESCRIPTION DRUG            Trulicity          Dulaglutide   \n",
       "4  HUMAN PRESCRIPTION DRUG            Trulicity          Dulaglutide   \n",
       "\n",
       "        DOSAGEFORMNAME     ROUTENAME STARTMARKETINGDATE ENDMARKETINGDATE  \\\n",
       "0  INJECTION, SOLUTION  SUBCUTANEOUS         1987-07-10              NaT   \n",
       "1  INJECTION, SOLUTION   INTRAVENOUS         2012-06-01              NaT   \n",
       "2             SOLUTION   INTRAVENOUS         1950-07-12              NaT   \n",
       "3  INJECTION, SOLUTION  SUBCUTANEOUS         2014-09-18              NaT   \n",
       "4  INJECTION, SOLUTION  SUBCUTANEOUS         2014-09-18              NaT   \n",
       "\n",
       "  MARKETINGCATEGORYNAME APPLICATIONNUMBER            LABELERNAME  \\\n",
       "0                   NDA         NDA018781  Eli Lilly and Company   \n",
       "1                   NDA         NDA202008  Eli Lilly and Company   \n",
       "2                   NDA         NDA007529  Eli Lilly and Company   \n",
       "3                   BLA         BLA125469  Eli Lilly and Company   \n",
       "4                   BLA         BLA125469  Eli Lilly and Company   \n",
       "\n",
       "         SUBSTANCENAME ACTIVE_NUMERATOR_STRENGTH ACTIVE_INGRED_UNIT  \\\n",
       "0                WATER                         1              mL/mL   \n",
       "1     FLORBETAPIR F-18                        51             mCi/mL   \n",
       "2  QUINIDINE GLUCONATE                        80              mg/mL   \n",
       "3          DULAGLUTIDE                      0.75            mg/.5mL   \n",
       "4          DULAGLUTIDE                       1.5            mg/.5mL   \n",
       "\n",
       "                                       PHARM_CLASSES  \\\n",
       "0                                                NaN   \n",
       "1  Radioactive Diagnostic Agent [EPC],Positron Em...   \n",
       "2  Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhib...   \n",
       "3  GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...   \n",
       "4  GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...   \n",
       "\n",
       "  LISTING_RECORD_CERTIFIED_THROUGH  \n",
       "0                       2019-12-31  \n",
       "1                       2019-12-31  \n",
       "2                       2019-12-31  \n",
       "3                       2019-12-31  \n",
       "4                       2019-12-31  "
      ]
     },
     "execution_count": 242,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# drop useless column\n",
    "product = product.drop(columns=['DEASCHEDULE'])\n",
    "product = product.drop(columns=['NDC_EXCLUDE_FLAG'])\n",
    "product = product.drop(columns=['PROPRIETARYNAMESUFFIX'])\n",
    "product.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 243,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PRODUCTID</th>\n",
       "      <th>PRODUCTNDC</th>\n",
       "      <th>PRODUCTTYPENAME</th>\n",
       "      <th>PROPRIETARYNAME</th>\n",
       "      <th>NONPROPRIETARYNAME</th>\n",
       "      <th>DOSAGEFORMNAME</th>\n",
       "      <th>ROUTENAME</th>\n",
       "      <th>STARTMARKETINGDATE</th>\n",
       "      <th>ENDMARKETINGDATE</th>\n",
       "      <th>MARKETINGCATEGORYNAME</th>\n",
       "      <th>APPLICATIONNUMBER</th>\n",
       "      <th>LABELERNAME</th>\n",
       "      <th>SUBSTANCENAME</th>\n",
       "      <th>ACTIVE_NUMERATOR_STRENGTH</th>\n",
       "      <th>ACTIVE_INGRED_UNIT</th>\n",
       "      <th>PHARM_CLASSES</th>\n",
       "      <th>LISTING_RECORD_CERTIFIED_THROUGH</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0002-0800_4bb5d1cb-0fa7-48c7-9f6d-8d45f9b91649</td>\n",
       "      <td>0002-0800</td>\n",
       "      <td>HUMAN OTC DRUG</td>\n",
       "      <td>Sterile Diluent</td>\n",
       "      <td>diluent</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>1987-07-10</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA018781</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>WATER</td>\n",
       "      <td>1</td>\n",
       "      <td>mL/mL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0002-1200_957ee1b5-dfa7-4e3f-96e1-6bed1ffc0abe</td>\n",
       "      <td>0002-1200</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Amyvid</td>\n",
       "      <td>Florbetapir F 18</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>INTRAVENOUS</td>\n",
       "      <td>2012-06-01</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA202008</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>FLORBETAPIR F-18</td>\n",
       "      <td>51</td>\n",
       "      <td>mCi/mL</td>\n",
       "      <td>Radioactive Diagnostic Agent [EPC],Positron Em...</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0002-1407_14757f9d-f641-4836-acf3-229265588d1d</td>\n",
       "      <td>0002-1407</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Quinidine Gluconate</td>\n",
       "      <td>Quinidine Gluconate</td>\n",
       "      <td>SOLUTION</td>\n",
       "      <td>INTRAVENOUS</td>\n",
       "      <td>1950-07-12</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NDA007529</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>QUINIDINE GLUCONATE</td>\n",
       "      <td>80</td>\n",
       "      <td>mg/mL</td>\n",
       "      <td>Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhib...</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0002-1433_7b0ec07f-bffa-467f-978a-45b1315107e5</td>\n",
       "      <td>0002-1433</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Trulicity</td>\n",
       "      <td>Dulaglutide</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>2014-09-18</td>\n",
       "      <td>NaT</td>\n",
       "      <td>BLA</td>\n",
       "      <td>BLA125469</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>DULAGLUTIDE</td>\n",
       "      <td>0.75</td>\n",
       "      <td>mg/.5mL</td>\n",
       "      <td>GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0002-1434_7b0ec07f-bffa-467f-978a-45b1315107e5</td>\n",
       "      <td>0002-1434</td>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>Trulicity</td>\n",
       "      <td>Dulaglutide</td>\n",
       "      <td>INJECTION, SOLUTION</td>\n",
       "      <td>SUBCUTANEOUS</td>\n",
       "      <td>2014-09-18</td>\n",
       "      <td>NaT</td>\n",
       "      <td>BLA</td>\n",
       "      <td>BLA125469</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>DULAGLUTIDE</td>\n",
       "      <td>1.5</td>\n",
       "      <td>mg/.5mL</td>\n",
       "      <td>GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...</td>\n",
       "      <td>2019-12-31</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        PRODUCTID PRODUCTNDC  \\\n",
       "0  0002-0800_4bb5d1cb-0fa7-48c7-9f6d-8d45f9b91649  0002-0800   \n",
       "1  0002-1200_957ee1b5-dfa7-4e3f-96e1-6bed1ffc0abe  0002-1200   \n",
       "2  0002-1407_14757f9d-f641-4836-acf3-229265588d1d  0002-1407   \n",
       "3  0002-1433_7b0ec07f-bffa-467f-978a-45b1315107e5  0002-1433   \n",
       "4  0002-1434_7b0ec07f-bffa-467f-978a-45b1315107e5  0002-1434   \n",
       "\n",
       "           PRODUCTTYPENAME      PROPRIETARYNAME   NONPROPRIETARYNAME  \\\n",
       "0           HUMAN OTC DRUG      Sterile Diluent              diluent   \n",
       "1  HUMAN PRESCRIPTION DRUG               Amyvid     Florbetapir F 18   \n",
       "2  HUMAN PRESCRIPTION DRUG  Quinidine Gluconate  Quinidine Gluconate   \n",
       "3  HUMAN PRESCRIPTION DRUG            Trulicity          Dulaglutide   \n",
       "4  HUMAN PRESCRIPTION DRUG            Trulicity          Dulaglutide   \n",
       "\n",
       "        DOSAGEFORMNAME     ROUTENAME STARTMARKETINGDATE ENDMARKETINGDATE  \\\n",
       "0  INJECTION, SOLUTION  SUBCUTANEOUS         1987-07-10              NaT   \n",
       "1  INJECTION, SOLUTION   INTRAVENOUS         2012-06-01              NaT   \n",
       "2             SOLUTION   INTRAVENOUS         1950-07-12              NaT   \n",
       "3  INJECTION, SOLUTION  SUBCUTANEOUS         2014-09-18              NaT   \n",
       "4  INJECTION, SOLUTION  SUBCUTANEOUS         2014-09-18              NaT   \n",
       "\n",
       "  MARKETINGCATEGORYNAME APPLICATIONNUMBER            LABELERNAME  \\\n",
       "0                   NDA         NDA018781  Eli Lilly and Company   \n",
       "1                   NDA         NDA202008  Eli Lilly and Company   \n",
       "2                   NDA         NDA007529  Eli Lilly and Company   \n",
       "3                   BLA         BLA125469  Eli Lilly and Company   \n",
       "4                   BLA         BLA125469  Eli Lilly and Company   \n",
       "\n",
       "         SUBSTANCENAME ACTIVE_NUMERATOR_STRENGTH ACTIVE_INGRED_UNIT  \\\n",
       "0                WATER                         1              mL/mL   \n",
       "1     FLORBETAPIR F-18                        51             mCi/mL   \n",
       "2  QUINIDINE GLUCONATE                        80              mg/mL   \n",
       "3          DULAGLUTIDE                      0.75            mg/.5mL   \n",
       "4          DULAGLUTIDE                       1.5            mg/.5mL   \n",
       "\n",
       "                                       PHARM_CLASSES  \\\n",
       "0                                                NaN   \n",
       "1  Radioactive Diagnostic Agent [EPC],Positron Em...   \n",
       "2  Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhib...   \n",
       "3  GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...   \n",
       "4  GLP-1 Receptor Agonist [EPC],Glucagon-Like Pep...   \n",
       "\n",
       "  LISTING_RECORD_CERTIFIED_THROUGH  \n",
       "0                       2019-12-31  \n",
       "1                       2019-12-31  \n",
       "2                       2019-12-31  \n",
       "3                       2019-12-31  \n",
       "4                       2019-12-31  "
      ]
     },
     "execution_count": 243,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# remove duplicate by PRODUCTNDC and ACTIVE_NUMERATOR_STRENGTH\n",
    "product = product.drop_duplicates(['PRODUCTNDC','ACTIVE_NUMERATOR_STRENGTH'])\n",
    "product.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 244,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/zex0012/Desktop/COMP-4447/python/dst1_env/lib/python3.7/site-packages/ipykernel_launcher.py:5: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/indexing.html#indexing-view-versus-copy\n",
      "  \"\"\"\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x16233f390>"
      ]
     },
     "execution_count": 244,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# The distribution plot of ACTIVE_NUMERATOR_STRENGTH where the ACTIVE_INGRED_UNIT is mg/1\n",
    "# The reason to create this plot is that mg/1 is the top number of unit in the dataset.\n",
    "# This visualization provides normally the ingredient in a medicine is small amount \n",
    "product_mg1 = product.loc[product['ACTIVE_INGRED_UNIT'] == 'mg/1']\n",
    "product_mg1['ACTIVE_NUMERATOR_STRENGTH'] = product_mg1.ACTIVE_NUMERATOR_STRENGTH.astype('float64')\n",
    "sns.distplot(product_mg1['ACTIVE_NUMERATOR_STRENGTH'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 261,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/zex0012/Desktop/COMP-4447/python/dst1_env/lib/python3.7/site-packages/ipykernel_launcher.py:2: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/indexing.html#indexing-view-versus-copy\n",
      "  \n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PRODUCTTYPENAME</th>\n",
       "      <th>total</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>HUMAN OTC DRUG</td>\n",
       "      <td>41624</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HUMAN PRESCRIPTION DRUG</td>\n",
       "      <td>40059</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>VACCINE</td>\n",
       "      <td>85</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>PLASMA DERIVATIVE</td>\n",
       "      <td>263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1795</th>\n",
       "      <td>CELLULAR THERAPY</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5037</th>\n",
       "      <td>NON-STANDARDIZED ALLERGENIC</td>\n",
       "      <td>2413</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5113</th>\n",
       "      <td>STANDARDIZED ALLERGENIC</td>\n",
       "      <td>142</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                  PRODUCTTYPENAME  total\n",
       "0                  HUMAN OTC DRUG  41624\n",
       "1         HUMAN PRESCRIPTION DRUG  40059\n",
       "167                       VACCINE     85\n",
       "276             PLASMA DERIVATIVE    263\n",
       "1795             CELLULAR THERAPY      5\n",
       "5037  NON-STANDARDIZED ALLERGENIC   2413\n",
       "5113      STANDARDIZED ALLERGENIC    142"
      ]
     },
     "execution_count": 261,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 2160x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "labeler = product[['PRODUCTTYPENAME']]\n",
    "labeler['total'] = labeler.groupby(['PRODUCTTYPENAME'])['PRODUCTTYPENAME'].transform('count')\n",
    "labeler = labeler.drop_duplicates(['PRODUCTTYPENAME'])\n",
    "\n",
    "g = sns.catplot(x=\"PRODUCTTYPENAME\", y=\"total\", kind=\"bar\", data=labeler)\n",
    "g.fig.set_size_inches(30,10)\n",
    "\n",
    "labeler"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 267,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>SUBSTANCENAME</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>WATER</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>FLORBETAPIR F-18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>QUINIDINE GLUCONATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DULAGLUTIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>GALCANEZUMAB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IXEKIZUMAB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>FLUOXETINE HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>ATOMOXETINE HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>OLANZAPINE; FLUOXETINE HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>DULOXETINE HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>OLANZAPINE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>BARICITINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>RALOXIFENE HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>TADALAFIL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>ABEMACICLIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>PRASUGREL HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>OLARATUMAB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>GEMCITABINE HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>INSULIN LISPRO</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>PEMETREXED DISODIUM HEPTAHYDRATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>RAMUCIRUMAB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>INSULIN GLARGINE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>NECITUMUMAB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>INSULIN HUMAN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>TERIPARATIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>DACLATASVIR DIHYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>TRIAMCINOLONE ACETONIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>BELATACEPT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>DASATINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122607</th>\n",
       "      <td>OCTOCRYLENE; AVOBENZONE; OCTINOXATE; OCTISALATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122751</th>\n",
       "      <td>MENTHOL; EUCALYPTUS OIL; CAMPHOR (NATURAL)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122776</th>\n",
       "      <td>ALBUMIN (HUMAN)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122863</th>\n",
       "      <td>OCTINOXATE; OCTISALATE; ENSULIZOLE; TITANIUM D...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122931</th>\n",
       "      <td>ARNICA MONTANA; LEDUM PALUSTRE TWIG</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123044</th>\n",
       "      <td>AVANAFIL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123060</th>\n",
       "      <td>OCTISALATE; ZINC OXIDE; OCTINOXATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123062</th>\n",
       "      <td>FOSCARNET SODIUM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123069</th>\n",
       "      <td>CHLOROXYLENOL; ISOPROPYL ALCOHOL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123117</th>\n",
       "      <td>MITOTANE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123118</th>\n",
       "      <td>METYRAPONE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123151</th>\n",
       "      <td>MIFEPRISTONE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123227</th>\n",
       "      <td>TITANIUM DIOXIDE; OCTISALATE; OCTINOXATE; OCTO...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123230</th>\n",
       "      <td>OCTISALATE; TITANIUM DIOXIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123236</th>\n",
       "      <td>TITANIUM DIOXIDE; OCTISALATE; OCTINOXATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123238</th>\n",
       "      <td>OCTINOXATE; OCTOCRYLENE; OCTISALATE; OXYBENZON...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123264</th>\n",
       "      <td>TITANIUM DIOXIDE; OCTISALATE; OCTINOXATE; OCTO...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123284</th>\n",
       "      <td>GARCINIA CAMBOGIA FRUIT; PSYLLIUM HUSK</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123340</th>\n",
       "      <td>CHLORAMBUCIL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123342</th>\n",
       "      <td>THIOGUANINE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123477</th>\n",
       "      <td>BETAMETHASONE SODIUM PHOSPHATE; BETAMETHASONE ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123528</th>\n",
       "      <td>LOMITAPIDE MESYLATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123534</th>\n",
       "      <td>METRELEPTIN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123558</th>\n",
       "      <td>AZADIRACHTA INDICA SEED OIL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123575</th>\n",
       "      <td>AVOBENZONE; ENSULIZOLE; ENZACAMENE; OCTINOXATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123576</th>\n",
       "      <td>AVOBENZONE; OXYBENZONE; ENSULIZOLE; OCTOCRYLEN...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123578</th>\n",
       "      <td>AVOBENZONE; ENSULIZOLE; OXYBENZONE; OCTINOXATE...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123699</th>\n",
       "      <td>HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123784</th>\n",
       "      <td>MICONAZOLE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124007</th>\n",
       "      <td>EDETATE CALCIUM DISODIUM</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>8708 rows  1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            SUBSTANCENAME\n",
       "0                                                   WATER\n",
       "1                                        FLORBETAPIR F-18\n",
       "2                                     QUINIDINE GLUCONATE\n",
       "3                                             DULAGLUTIDE\n",
       "5                                            GALCANEZUMAB\n",
       "6                                              IXEKIZUMAB\n",
       "9                                FLUOXETINE HYDROCHLORIDE\n",
       "10                              ATOMOXETINE HYDROCHLORIDE\n",
       "13                   OLANZAPINE; FLUOXETINE HYDROCHLORIDE\n",
       "18                               DULOXETINE HYDROCHLORIDE\n",
       "25                                             OLANZAPINE\n",
       "29                                            BARICITINIB\n",
       "30                               RALOXIFENE HYDROCHLORIDE\n",
       "37                                              TADALAFIL\n",
       "41                                            ABEMACICLIB\n",
       "43                                PRASUGREL HYDROCHLORIDE\n",
       "48                                             OLARATUMAB\n",
       "49                                                    NaN\n",
       "50                              GEMCITABINE HYDROCHLORIDE\n",
       "52                                         INSULIN LISPRO\n",
       "57                       PEMETREXED DISODIUM HEPTAHYDRATE\n",
       "62                                            RAMUCIRUMAB\n",
       "66                                       INSULIN GLARGINE\n",
       "67                                            NECITUMUMAB\n",
       "73                                          INSULIN HUMAN\n",
       "75                                           TERIPARATIDE\n",
       "85                            DACLATASVIR DIHYDROCHLORIDE\n",
       "89                                TRIAMCINOLONE ACETONIDE\n",
       "90                                             BELATACEPT\n",
       "92                                              DASATINIB\n",
       "...                                                   ...\n",
       "122607    OCTOCRYLENE; AVOBENZONE; OCTINOXATE; OCTISALATE\n",
       "122751         MENTHOL; EUCALYPTUS OIL; CAMPHOR (NATURAL)\n",
       "122776                                    ALBUMIN (HUMAN)\n",
       "122863  OCTINOXATE; OCTISALATE; ENSULIZOLE; TITANIUM D...\n",
       "122931                ARNICA MONTANA; LEDUM PALUSTRE TWIG\n",
       "123044                                           AVANAFIL\n",
       "123060                 OCTISALATE; ZINC OXIDE; OCTINOXATE\n",
       "123062                                   FOSCARNET SODIUM\n",
       "123069                   CHLOROXYLENOL; ISOPROPYL ALCOHOL\n",
       "123117                                           MITOTANE\n",
       "123118                                         METYRAPONE\n",
       "123151                                       MIFEPRISTONE\n",
       "123227  TITANIUM DIOXIDE; OCTISALATE; OCTINOXATE; OCTO...\n",
       "123230                       OCTISALATE; TITANIUM DIOXIDE\n",
       "123236           TITANIUM DIOXIDE; OCTISALATE; OCTINOXATE\n",
       "123238  OCTINOXATE; OCTOCRYLENE; OCTISALATE; OXYBENZON...\n",
       "123264  TITANIUM DIOXIDE; OCTISALATE; OCTINOXATE; OCTO...\n",
       "123284             GARCINIA CAMBOGIA FRUIT; PSYLLIUM HUSK\n",
       "123340                                       CHLORAMBUCIL\n",
       "123342                                        THIOGUANINE\n",
       "123477  BETAMETHASONE SODIUM PHOSPHATE; BETAMETHASONE ...\n",
       "123528                                LOMITAPIDE MESYLATE\n",
       "123534                                        METRELEPTIN\n",
       "123558                        AZADIRACHTA INDICA SEED OIL\n",
       "123575     AVOBENZONE; ENSULIZOLE; ENZACAMENE; OCTINOXATE\n",
       "123576  AVOBENZONE; OXYBENZONE; ENSULIZOLE; OCTOCRYLEN...\n",
       "123578  AVOBENZONE; ENSULIZOLE; OXYBENZONE; OCTINOXATE...\n",
       "123699     HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL\n",
       "123784                                         MICONAZOLE\n",
       "124007                           EDETATE CALCIUM DISODIUM\n",
       "\n",
       "[8708 rows x 1 columns]"
      ]
     },
     "execution_count": 267,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "substance = product[['SUBSTANCENAME']]\n",
    "substance = substance.drop_duplicates(['SUBSTANCENAME'])\n",
    "substance"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Data set and motivation:"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Our dataset is about the drug products in the United States. The reason we collect the data is that sometimes we wish to purchase OTC drugs, there is no list about the dosage and the curative effect, so it is hard to purchase the right drugs. We need to search each individual drug we wish to purchase. Thus, we want to reorganize this raw dataset as a guide of drugs. \n",
    "    \n",
    "The data contains: ProductID which is the concatenation of the NDCproduct code and SPL documentID, ProductNDC which is the labeler code and product code segments of the National Drug Code number, ProductTypeName which is the type of product, ProprietaryName which is the trade name, ProprietaryNameSuffix which is the suffix to the proprietary name, NonProprietaryName which is the active ingredient(s) of the product, DosageFormName which is the translation of the DosageForm Code, RouteName which is the translation of the Route Code, StartMarketingDate which is the starting date of its marketing of the drug product, EndMarketingDate which is the ending date the product will no longer be available on the market, MarketingCategoryName which is the final marketed product categories, LabelerName which is the name of the company, SubstanceName which is the active ingredient list, StrengthNumber which is the strength values of each active ingredient, StrengthUnit which is the units to be used with the strength values, Pharm_Classes which is the reported pharmacological class categories, DEASchedule which is the assigned DEA Schedule number, NDC_Exclude_Flag which is check whether the product has been removed/excluded from the NDC Directory for failure to respond to FDAs requests for correction to deficient or non-compliant submissions, Listing_Record_Certified_Through which it the date when the listing record will expire."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Actual task definition/Research question:"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "There are several real-world questions we wish to solve; the first question is the data is a raw data so there are a lot of duplication and misleading. For example, the data contains two different drugs but with same curative effect or two different drugs with same name but different curative effect. Also, it contains drugs which is not approved to use today. If people read the raw data and wish to purchase the medicine, the duplicate and misleading parts make people do not know what the right medicine is to choose. The raw dataset will cause a lot of trouble. if people wish to purchase a medicine in a rush, read the raw dataset will waste lots of time on finding the right medicine. Thus, our goal is to make this dataset readable and remove all the misleading and duplicate part so that this dataset will become the guide for people to purchase medicine in the United States. Also, it is easier for doctors to offer prescriptions because the dataset is more readable.\n",
    "\n",
    "The second is that we want to make some visualizations about each type of medicine, we want to know which type of drug is popular in our world and which type of drug have better prospects. This can let the drug manufactures know which type of drug they can make in the future. \n",
    "\n",
    "The third is that we wish to combine the same curative effect drug by the OTC drug dosage name, and we want to make the distribution of all the OTC drug dosage name. The reason is that OTC drug is people normally use. However, sometimes before people purchase the drug, they need to know how to use the drug. For example, if someone allergy with capsule they need to purchase other form of drug with the same effect. Thus, it is better to combine the drugs. Also, we want to make the distribution to analyze which type of drug dosage name is the most popular one so drug manufactures based on the type of medicine and the dosage name to make medicine in the future."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
